High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. - Test2 - elhamkhani - TriplyDB

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.

http://www.wikidata.org/entity/Q35112199

about

Acute lymphoblastic leukaemia Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved Issues Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?How I treat pediatric acute myeloid leukemia Childhood acute myeloid leukaemia Current Management of Childhood Acute Myeloid Leukemia.Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.Pre-hematopoietic stem cell transplant lung function and pulmonary complications in children.Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies.The policy statement of the American Academy of Pediatrics -- children as hematopoietic stem cell donors -- a proposal of modifications for application in the UK.Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy.Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia.Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.Rapid generation of NY-ESO-1-specific CD4(+) THELPER1 cells for adoptive T-cell therapy.Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007 Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia.Health-Related Quality of Life among Children and Adolescents during Hematopoietic Stem Cell Transplant Recovery.Natural killer cell therapy in children with relapsed leukemia.Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.Measurements of treatment response in childhood acute leukemia.Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation.Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives Haploidentical transplantation for hematologic malignancies: where do we stand?Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia.Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome.Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation New strategies for haploidentical transplantation.Should minimal residual disease monitoring in acute lymphoblastic leukemia be standard of care?Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia.Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation.Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation.The current role of T cell depletion in paediatric stem cell transplantation.Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.

P2860

Q24602387-38479AD2-6538-4057-8A3D-A69FEE94CAA0 Q26750671-4EF078FA-0186-4469-8F22-F28BF39DDCC8 Q26781328-6302644A-D387-4ABF-9539-AD5057B8BFC8 Q26830857-E07F2A7B-4C2F-4DF6-83F8-730CB03F5A20 Q26992280-B6633A74-4105-465A-A4F7-B494915A1C9F Q27005960-5291137D-BC55-4A3A-9F64-33E512965A93 Q30244036-3D249843-72A8-4195-B6EA-A44FFF7A577E Q33398162-2CF2CCEB-6BFE-4BB8-815E-BF22DFACDE3C Q33811274-A3369D1C-1E6C-4E12-89BA-1552732AAD41 Q34460533-18E0FC42-1DAA-47BF-B309-BA4B6F14E882 Q34493958-3DDA5D07-0105-4034-8499-CEF3E7056CF5 Q34627218-A33ED997-0325-4189-AA5F-FA3F83550ACD Q34674124-6F7EF87E-2FB0-443D-AB82-01B75EB0E8DF Q34881512-6630F8F4-E96A-4BD9-92E9-620ED09311E9 Q35060682-945E157C-DF45-48F8-9D24-0B8FBBCA5755 Q35799353-4A0B267A-97A6-4E4F-96DA-536F45FDCD6E Q36058482-B1045466-A350-4CFE-84F6-3A6294360193 Q36100435-ABE24732-8187-4FEE-A6F7-3A3E7EEA6AF8 Q36164963-44D59620-9070-46F8-9CA0-0748AFA813D2 Q36251948-E027B8A4-5D0C-4F28-A54D-0613FE767923 Q36256781-E7FF834B-A749-41BE-A57F-1BE06B85627B Q36398704-6F9ADFB7-D37A-4317-8B6F-C65B2992583D Q36488188-9DDAFEA4-7E96-4B50-B078-1AD9DF38C9DC Q36509641-E2A1304F-D545-43EC-BA4B-8648EE1C840C Q36513773-10B833ED-166C-4D6E-ABC5-8F0C307BA315 Q36560134-9AB7FE4F-FBE3-44B2-8550-46322CC194C3 Q36804215-7CED1F99-1605-4BFA-835D-226D54A11C46 Q36854831-7789DB8A-5ED8-40D0-90E6-913510EA8641 Q36910405-2B2B916C-5D19-4C6E-B56E-831B83F466B8 Q37148120-7A35EEEE-D2D0-4030-974E-2A3B4D388923 Q37151698-71666D97-3742-4B5C-B418-ED54B57EBF28 Q37154973-6FDD1727-D17F-44DC-8F06-058A4BFD318D Q37227672-C479AA29-7F04-421B-9C68-6055F9FF9A84 Q37978777-069CFEF6-AA23-4C2E-A2A8-2EE7366EF955 Q37989006-346926AB-E412-4E22-8975-B3241820695D Q38028808-2A8215F1-D1AD-480E-8BFE-7BB3E4F302FF Q38035452-855A5CD2-ECCF-4913-AA09-B5DAFF9966BC Q38105123-EDE6A4E8-5A85-4B0D-9ACF-F21B9BAF4B2B Q38110308-26F0CD98-86E3-45A4-B009-A03E014BF39C Q38113738-818C3AA0-D6A4-44DC-9EF3-EC06AA2F4ECF

P2860

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.

http://www.wikidata.org/entity/Q35112199

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

High success rate of hematopoi ...... with very high-risk leukemia.

@ast

High success rate of hematopoi ...... with very high-risk leukemia.

@en

type

label

High success rate of hematopoi ...... with very high-risk leukemia.

@ast

High success rate of hematopoi ...... with very high-risk leukemia.

@en

prefLabel

High success rate of hematopoi ...... with very high-risk leukemia.

@ast

High success rate of hematopoi ...... with very high-risk leukemia.

@en

P1433

Q35112199-CA0DC1DC-129F-4907-A913-1B023F65E077

P1476

Q35112199-16A3C5E7-9A82-4B0E-9E13-5B31FD5D9A2B

P2093

Q35112199-18CF2F1E-CBC6-49DE-9525-3BE7E51A48A8

Q35112199-26EA3578-724A-4D06-A732-6A5D1CFC144C

Q35112199-2761932A-D468-4732-8813-BB22AA030F64

Q35112199-40358BCD-E024-4644-8898-08239A2EE3FC

Q35112199-52BF99B0-BD02-440A-942B-CC20B81E975B

Q35112199-578567F7-5665-42F9-B858-EEA80CEF7F19

Q35112199-84F2BEC4-0346-40A6-A9FA-F3F441DCB66A

Q35112199-9C1D91AE-E0CB-40EC-B12B-D5D99D500BFF

Q35112199-A7B043D5-66CB-43A6-8F7C-63B7335969C4

Q35112199-CFB83C04-7AC9-4AE9-A29B-58C99001C501

P2860

Q35112199-0118725B-35B0-46BC-8F0E-77D0CEE3646E

Q35112199-01AC2D4B-945D-4E97-8A29-5F515DC577ED

Q35112199-057E758D-1AE7-44EF-8F2B-43E89529F31A

Q35112199-0CB226CA-7D97-44F3-AC1E-E3CB94192C95

Q35112199-13BB39AB-DCDD-403F-88E9-81460C4FB642

Q35112199-141BD02F-347A-460F-8C48-A5722947349B

Q35112199-18F6E7EF-EF2D-4ECC-854F-55A245DA679E

Q35112199-1DB34505-6A0B-410C-9B31-AF5D18012E6D

Q35112199-1EA6D562-4E91-4CD0-869B-00538D033825

Q35112199-206BFBAE-C49D-4D75-AB8B-A102420508F9

P304

Q35112199-995FA205-EAE3-46B9-9486-371370AD82A8

P31

Q35112199-3EFDD1F0-DF82-478C-A6E8-117A4F90C808

P356

Q35112199-DE4F5288-0739-435F-8D5F-C27E4EF3C31F

P407

Q35112199-B824D326-3604-4D46-BD83-37C0E4ED6008

P433

Q35112199-7EAF1ABB-A91E-4193-B2DC-547D82DB4016

P478

Q35112199-CAD80487-61E0-4B5F-A9A1-3E3EE5DA4910

P50

Q35112199-2CBF1C69-35B7-442C-A8CF-A1FDAA2688F6

Q35112199-688E2C6D-789C-4C64-9324-0F0483355FB6

Q35112199-B85E8895-2C58-40F1-8832-2E7AF7D6CB8A

Q35112199-FB53F2FF-100E-4EDD-9A1E-3F5A8A979B5F

P577

Q35112199-1B628689-F78D-439F-AFEE-BF11C39ED15D

P5875

Q35112199-14DEB8BB-0A58-498F-A1CB-2B89537F71DE

P698

Q35112199-771D0A26-99A5-4BC2-8F93-BBF857C8AF02

P921

Q35112199-811C4475-8E22-42C0-9675-3FB7AF4EED21

P932

Q35112199-AAFBF4E0-4823-4DAD-BBEA-A26EF6288E1D

P356

BLOOD-2011-01-333070

P1433

P1476

High success rate of hematopoi ...... with very high-risk leukemia.

@en

P2093

Asha Pillai

http://www.w3.org/2001/XMLSchema#string

Christine Hartford

http://www.w3.org/2001/XMLSchema#string

Dario Campana

http://www.w3.org/2001/XMLSchema#string

Deqing Pei

http://www.w3.org/2001/XMLSchema#string

Elaine Coustan-Smith

http://www.w3.org/2001/XMLSchema#string

Jie Yang

http://www.w3.org/2001/XMLSchema#string

John T Sandlund

http://www.w3.org/2001/XMLSchema#string

Joseph H Laver

http://www.w3.org/2001/XMLSchema#string

Kwan Gan

http://www.w3.org/2001/XMLSchema#string

Mari Dallas

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic stem cell transplantation: a global perspective

Treating childhood acute lymphoblastic leukemia without cranial irradiation

Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Mar

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.

Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies.

Hematopoietic stem cell transplantation for leukemia

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

P304

223-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-01-333070

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Brandon M Triplett

Ashok Srinivasan

Jeffrey Rubnitz

P577

2011-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51165896

http://www.w3.org/2001/XMLSchema#string

P698

21613256

http://www.w3.org/2001/XMLSchema#string

P921

P932

3138677

http://www.w3.org/2001/XMLSchema#string